Biosimilars are highly similar products of an innovator biologic used to decrease costs. The nocebo effect is an increase in symptoms resulting from a patient’s negative perceptions about a biosimilar. Multistep notification, organized transition, and opt-out ability constitute a framework for switching patients from a reference product to a biosimilar.